Summary & Overview
CPT 36581: Complete Replacement of Central Venous Access Device
CPT code 36581 is a surgical procedure for the complete replacement of a central venous access device using the same venous access site. This code is significant in the national healthcare landscape, as central venous access devices are critical for patients needing ongoing intravenous treatments. The procedure is most commonly performed in outpatient hospital settings, reflecting the shift toward ambulatory care for complex interventions.
Major payers covering this procedure include Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare. Understanding coverage policies and reimbursement benchmarks for 36581 is essential for providers, administrators, and policy analysts to ensure compliance and optimize care delivery.
This publication provides a comprehensive overview of 36581, including clinical context, payer coverage, and related coding information. Readers will gain insights into typical use cases, associated diagnoses, and relevant modifiers. The article also highlights related CPT codes for similar procedures, offering a broader perspective on vascular access device management. Policy updates and coding benchmarks are discussed to inform stakeholders about current trends and requirements in medical billing for central venous access device replacement.
CPT Code Overview
CPT code 36581 describes the complete replacement of a central venous access device through the same venous access site. This procedure is classified under surgery and is typically performed in an outpatient hospital setting (Place of Service 22). Central venous access devices are essential for patients requiring long-term intravenous therapies, such as chemotherapy, parenteral nutrition, or frequent blood draws. The replacement procedure ensures continued vascular access when the existing device is no longer functional or has complications, maintaining patient care and safety.
Clinical & Coding Specifications
Clinical Context
A patient with a previously placed central venous access device presents to the outpatient hospital setting due to a complication such as mechanical failure, infection, or the need for device management. The clinical workflow involves assessment of the device, determination that complete replacement is necessary, and performing the procedure through the same venous access site. The procedure is typically performed by a physician specializing in surgery, vascular and interventional radiology, or family medicine. The patient may have underlying conditions such as venous insufficiency or abnormal blood chemistry, and the replacement is indicated to restore reliable vascular access for ongoing medical treatments.
Coding Specifications
Modifiers:
-
Modifier
52(Reduced Services): Used when the procedure is partially completed or less than the full service described by the CPT code is provided. -
Modifier
59(Distinct Procedural Service): Used to indicate that the procedure is distinct or independent from other services performed on the same day.
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
208600000X | Surgery Physician |
2085R0202X | Radiology, Vascular & Interventional Radiology |
207Q00000X | Family Medicine Physician |
These specialties represent providers who commonly perform or manage central venous access device procedures.
Related Diagnoses
-
T82.590A: Other mechanical complication of other vascular grafts, initial encounter- Indicates a mechanical issue with a vascular graft or device, often necessitating replacement.
-
T82.7XXA: Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter- Represents infection or inflammation related to the vascular access device, which may require removal and replacement.
-
Z45.2: Encounter for adjustment and management of vascular access device- Used for visits focused on managing or replacing a vascular access device.
-
I87.2: Venous insufficiency (chronic) (peripheral)- Chronic venous insufficiency may complicate vascular access and necessitate device replacement.
-
R79.89: Other specified abnormal findings of blood chemistry- Abnormal blood chemistry findings may prompt evaluation and management of vascular access devices.
Related CPT Codes
| CPT Code | Description | Clinical Relationship |
|---|---|---|
36580 | Replacement, complete, of a tunneled centrally inserted central venous catheter, with subcutaneous port | Alternative procedure for patients with a tunneled catheter and port; may be used when port is present |
36582 | Replacement, complete, of a peripherally inserted central venous catheter (PICC), without subcutaneous port or pump | Alternative for patients with a PICC line; used when the device is peripherally inserted |
36556 | Insertion of non-tunneled centrally inserted central venous catheter | Related as an initial placement procedure; may precede replacement if device fails |
36589 | Removal of tunneled central venous catheter, without subcutaneous port or pump | Related as a removal procedure; may be performed prior to replacement or when device is no longer needed |
These codes are commonly used as alternatives or in sequence with 36581 depending on the clinical scenario and device type.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 36581 is $789.69, which is higher than the BUCA (average commercial) mean rate of $674.90. Among commercial payers, UnitedHealth Group has the highest mean rate at $1,050.72, while Aetna is the lowest at $459.67.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Aetna shows the tightest spread at $219.27, indicating less variability in rates, while UnitedHealth Group has the widest spread at $524.53, reflecting greater variability. Medicare's dispersion is $98.00, which is the narrowest among all payers, suggesting consistent reimbursement rates.
The table and chart below present the full breakdown of national benchmarks for CPT code 36581 across major payers.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.